Varghese, Shiji

Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease

Fowler, C., Rainey-Smith, S. R., Bird, S., Bomke, J., Bourgeat, P., Brown, B. M., Burnham, S. C., Bush, A. I., Chadunow, C., Collins, S., et al. (2021) · Journal of Alzheimer's Disease Reports

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 164

A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: a ‘C-reactive protein’ for psychiatrists and neurologists?

Eratne, D., Loi, S. M., Walia, N., Farrand, S., Li, Q.-X., Varghese, S., Walterfang, M., Evans, A., Mocellin, R., Dhiman, K., et al. (2020) · Australian & New Zealand Journal of Psychiatry

Dementia and Cognitive Impairment ResearchCerebrospinal fluid and hydrocephalus

Cited by 56

Cerebrospinal fluid neurofilament light chain is elevated in Niemann–Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response

Eratne, D., Loi, S. M., Li, Q.-X., Varghese, S., McGlade, A., Collins, S., Masters, C. L., Velakoulis, D., & Walterfang, M. (2020) · Australian & New Zealand Journal of Psychiatry

Lysosomal Storage Disorders ResearchGenetic Neurodegenerative Diseases

Cited by 30

Cerebrospinal fluid neurofilament light and cerebral atrophy in younger‐onset dementia and primary psychiatric disorders

Walia, N., Eratne, D., Loi, S. M., Farrand, S., Li, Q., Malpas, C. B., Varghese, S., Walterfang, M., Evans, A. H., Parker, S., et al. (2023) · Internal Medicine Journal

Dementia and Cognitive Impairment ResearchCerebrospinal fluid and hydrocephalus

Cited by 6